Journal of Neurology

, Volume 260, Issue 2, pp 558–571 | Cite as

Adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia: report of five cases and a new mutation

  • Kirk Kleinfeld
  • Bret Mobley
  • Peter Hedera
  • Adam Wegner
  • Subramaniam Sriram
  • Siddharama Pawate
Original Communication

Abstract

The objective of this work is to report on a series of five patients with adult-onset leukoencephalopathy with neuroaxonal spheroids and pigmented glia (ALSP). ALSP is a rare adult-onset leukodystrophy, which encompasses hereditary diffuse leukoencephalopathy with axonal spheroids and pigmentary orthochromatic leukodystrophy. This was a retrospective chart review and literature review. Five previously healthy women presented with a rapidly progressive neurological disorder at ages 39, 37, 40, 30, and 47, respectively. All five individuals were initially diagnosed as suffering from multiple sclerosis. The clinical courses of the five patients were dominated by progressive spastic quadriparesis (patient 5, newly diagnosed, has paraparesis at this time) and dementia. Brain magnetic resonance imaging (MRI) showed diffuse cerebral atrophy, corpus callosal atrophy, and diffuse T2 hyperintensities in the subcortical and periventricular white matter with no gadolinium enhancing lesions. Three patients showed involvement of pyramidal tracts from motor cortex to the brainstem. Cerebrospinal fluid was normal in all cases. Diagnosis of ALSP was established by biopsy (two cases) and autopsy (two cases). Histopathology showed the presence of neuroaxonal spheroids in all four cases and pigmented glia in three. In the fifth case, diagnosis was established by genetic analysis alone that showed a disease-causing mutation in the colony-stimulating factor 1 receptor (CSF1R) gene. Genetic analysis was done in three patients with available DNA, and identified the disease-causing mutation in all three, including a novel mutation F828S. ALSP may be suspected in adults with rapid to subacute progression of neurological disease when (1) MRI shows corpus callosal atrophy on a background of generalized brain atrophy and diffuse white matter disease without postcontrast enhancement, (2) CSF studies are normal, and (3) studies for systemic inflammatory diseases and specific leukodystrophies are normal. Diagnosis may be made without histopathological evidence when a disease-causing mutation is demonstrated in the CSF1R gene.

Keywords

Leukodystrophy White matter disease CSF1R Mutation 

References

  1. 1.
    Lyon G, Fattal-Valevski A, Kolodny EH (2006) Leukodystrophies: clinical and genetic aspects. Top Magn Reson Imaging 17(4):219–242PubMedCrossRefGoogle Scholar
  2. 2.
    Costello DJ, Eichler AF, Eichler FS (2009) Leukodystrophies: classification, diagnosis, and treatment. Neurologist 15(6):319–328PubMedCrossRefGoogle Scholar
  3. 3.
    Kohler W (2010) Leukodystrophies with late disease onset: an update. Curr Opin Neurol 23(3):234–241PubMedCrossRefGoogle Scholar
  4. 4.
    Sedel F et al (2008) Leukoencephalopathies associated with inborn errors of metabolism in adults. J Inherit Metab Dis 31(3):295–307PubMedCrossRefGoogle Scholar
  5. 5.
    Axelsson R et al (1984) Hereditary diffuse leukoencephalopathy with spheroids. Acta Psychiatr Scand Suppl 314:1–65PubMedGoogle Scholar
  6. 6.
    van der Knaap MS et al (2000) Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology 54(2):463–468PubMedCrossRefGoogle Scholar
  7. 7.
    Hancock N et al (2003) Hereditary diffuse leukoencephalopathy with spheroids. J Neurol Neurosurg Psychiatry 74(9):1345–1347PubMedCrossRefGoogle Scholar
  8. 8.
    Terada S et al (2004) An autopsy case of hereditary diffuse leukoencephalopathy with spheroids, clinically suspected of Alzheimer’s disease. Acta Neuropathol 108(6):538–545PubMedCrossRefGoogle Scholar
  9. 9.
    Baba Y et al (2006) Hereditary diffuse leukoencephalopathy with spheroids: clinical, pathologic and genetic studies of a new kindred. Acta Neuropathol 111(4):300–311PubMedCrossRefGoogle Scholar
  10. 10.
    Van Gerpen JA et al (2008) Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology 71(12):925–929PubMedCrossRefGoogle Scholar
  11. 11.
    Boisse L et al (2010) Neurological picture. Hereditary diffuse leukoencephalopathy with neuroaxonal spheroids: novel imaging findings. J Neurol Neurosurg Psychiatry 81(3):313–314PubMedCrossRefGoogle Scholar
  12. 12.
    Sundal C et al (2012) Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci 314(1–2):130–137Google Scholar
  13. 13.
    Mendes A et al (2010) Adult-onset leukodystrophy with axonal spheroids. J Neurol Sci 297(1–2):40–45PubMedCrossRefGoogle Scholar
  14. 14.
    Keegan BM et al (2008) Sporadic adult-onset leukoencephalopathy with neuroaxonal spheroids mimicking cerebral MS. Neurology 70(13 Pt 2):1128–1133PubMedGoogle Scholar
  15. 15.
    Freeman SH et al (2009) Adult-onset leukodystrophy with neuroaxonal spheroids: clinical, neuroimaging and neuropathologic observations. Brain Pathol 19(1):39–47PubMedCrossRefGoogle Scholar
  16. 16.
    Maillart E et al (2009) Rapid-onset frontal leukodystrophy with decreased diffusion coefficient and neuroaxonal spheroids. J Neurol 256(10):1649–1654PubMedCrossRefGoogle Scholar
  17. 17.
    Mateen FJ et al (2010) Sporadic leucodystrophy with neuroaxonal spheroids: persistence of DWI changes and neurocognitive profiles: a case study. J Neurol Neurosurg Psychiatry 81(6):619–622PubMedCrossRefGoogle Scholar
  18. 18.
    Mascalchi M et al (2006) CT and MR imaging of neuroaxonal leukodystrophy presenting as early-onset frontal dementia. AJNR Am J Neuroradiol 27(5):1037–1039PubMedGoogle Scholar
  19. 19.
    De Paula AM et al (2012) Sporadic diffuse leukoencephalopathy with axonal spheroids: report of a profuse and rapid cortical-spinal degeneration. Neurol Sci 33(4):905–909PubMedCrossRefGoogle Scholar
  20. 20.
    Moro-de-Casillas ML, Cohen ML, Riley DE (2004) Leukoencephalopathy with neuroaxonal spheroids (LENAS) presenting as the cerebellar subtype of multiple system atrophy. J Neurol Neurosurg Psychiatry 75(7):1070–1072PubMedCrossRefGoogle Scholar
  21. 21.
    Browne L, Sweeney BJ, Farrell MA (2003) Late-onset neuroaxonal leukoencephalopathy with spheroids and vascular amyloid. Eur Neurol 50(2):85–90PubMedCrossRefGoogle Scholar
  22. 22.
    Yamashita M, Yamamoto T (2002) Neuroaxonal leukoencephalopathy with axonal spheroids. Eur Neurol 48(1):20–25PubMedCrossRefGoogle Scholar
  23. 23.
    Gray F et al (1987) Pigmentary type of orthochromatic leukodystrophy (OLD): a new case with ultrastructural and biochemical study. J Neuropathol Exp Neurol 46(5):585–596PubMedCrossRefGoogle Scholar
  24. 24.
    Tunon T et al (1988) Leucodystrophy with pigmented glial and scavenger cells (pigmentary type of orthochromatic leucodystrophy). Neuropathol Appl Neurobiol 14(4):337–344PubMedGoogle Scholar
  25. 25.
    Calandriello L et al (1992) Biopsy diagnosis of a case of adult-onset orthochromatic leukodystrophy. Clinical and brain biopsy findings. Ital J Neurol Sci 13(9):787–792PubMedCrossRefGoogle Scholar
  26. 26.
    Shannon P, Wherrett JR, Nag S (1997) A rare form of adult-onset leukodystrophy: orthochromatic leukodystrophy with pigmented glia. Can J Neurol Sci 24(2):146–150PubMedGoogle Scholar
  27. 27.
    Sohn SY et al (2010) A case of pigmentary orthochromatic leukodystrophy with findings of proton MR spectroscopy and serial brain MRIs. J Neurol Sci 295(1–2):23–26PubMedCrossRefGoogle Scholar
  28. 28.
    Ali ZS, Van Der Voorn JP, Powers JM (2007) A comparative morphologic analysis of adult-onset leukodystrophy with neuroaxonal spheroids and pigmented glia—a role for oxidative damage. J Neuropathol Exp Neurol 66(7):660–672PubMedCrossRefGoogle Scholar
  29. 29.
    Wider C et al (2009) Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology 72(22):1953–1959PubMedCrossRefGoogle Scholar
  30. 30.
    Marotti JD et al (2004) Adult-onset leukodystrophy with neuroaxonal spheroids and pigmented glia: report of a family, historical perspective, and review of the literature. Acta Neuropathol 107(6):481–488PubMedCrossRefGoogle Scholar
  31. 31.
    Itoh K et al (2006) Autosomal dominant leukodystrophy with axonal spheroids and pigmented glia: clinical and neuropathological characteristics. Acta Neuropathol 111(1):39–45PubMedCrossRefGoogle Scholar
  32. 32.
    Wong JC, Chow TW, Hazrati LN (2011) Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia can present as frontotemporal dementia syndrome. Dement Geriatr Cogn Disord 32(2):150–158PubMedCrossRefGoogle Scholar
  33. 33.
    Tan K et al (2012) Adult-onset leucodystrophy with neuroaxonal spheroids and pigmented glia (ALSP): report of a new kindred. Neuropathol Appl Neurobiol 38(1):95–100Google Scholar
  34. 34.
    Rademakers R et al (2012) Mutations in the colony-stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 44(2):200–205CrossRefGoogle Scholar
  35. 35.
    Kinoshita M et al (2012) Hereditary diffuse leukoencephalopathy with axonal spheroids caused by R782H mutation in CSF1R: case report. J Neurol Sci 318(1–2):115–118PubMedCrossRefGoogle Scholar
  36. 36.
    Ellison D (2004) Pathologic reactions in the CNS, in Neuropathology: a reference text of CNS pathology. Mosby, Edinburgh, pp 3–25Google Scholar
  37. 37.
    Schiffmann R, van der Knaap MS (2009) Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 72(8):750–759PubMedCrossRefGoogle Scholar
  38. 38.
    Hesselink JR (2006) Differential diagnostic approach to MR imaging of white matter diseases. Top Magn Reson Imaging 17(4):243–263PubMedCrossRefGoogle Scholar
  39. 39.
    Moser HW, Mahmood A, Raymond GV (2007) X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3(3):140–151PubMedCrossRefGoogle Scholar
  40. 40.
    Eichler F et al (2007) Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Arch Neurol 64(5):659–664PubMedCrossRefGoogle Scholar
  41. 41.
    Liem MK et al (2007) Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL. Stroke 38(3):923–928PubMedCrossRefGoogle Scholar
  42. 42.
    O’Sullivan M et al (2001) MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 56(5):628–634PubMedCrossRefGoogle Scholar
  43. 43.
    Chabriat H et al (2009) Cadasil. Lancet Neurol 8(7):643–653PubMedCrossRefGoogle Scholar
  44. 44.
    Levin N et al (2008) Leukoencephalopathy with neuroaxonal spheroids presenting as frontotemporal dementia. Isr Med Assoc J 10(5):386–387PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Kirk Kleinfeld
    • 1
  • Bret Mobley
    • 2
  • Peter Hedera
    • 1
  • Adam Wegner
    • 1
  • Subramaniam Sriram
    • 1
  • Siddharama Pawate
    • 1
  1. 1.Department of Neurology, Vanderbilt Multiple Sclerosis CenterVanderbilt University Medical CenterNashvilleUSA
  2. 2.Division of Neuropathology, Department of PathologyVanderbilt University Medical CenterNashvilleUSA

Personalised recommendations